Home
Aurigene Oncology Limited

Aurigene Oncology Limited Market Share Analysis for April 2026

We aspire to build a global biopharmaceutical company, ensuring quality cancer medicines to patients through accelerated drug discovery services.

Health > Biotechnology and Pharmaceuticals

Domainaurigene.com

Year Founded2001

Employees501 - 1000

Annual Revenue$100M - $200M

Aurigene Oncology Limited

Aurigene Oncology Limited (including company regionals)

aurigene.com

See more website traffic and engagement information

Aurigene Oncology Limited Revenue up to April 2026 is 100M - 200M

revenue generated by Aurigene Oncology Limited top domains

Aurigene Oncology Limited top domains revenue over 3 years

Revenue for Aurigene Oncology Limited top domains

aurigene.com100M - 200M

See more with Sales Intelligence

Total visits to Aurigene Oncology Limited's top domains

Understand Aurigene Oncology Limited market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aurigene.com7.9K

See more with Sales Intelligence

Avg. visit duration in Aurigene Oncology Limited's top domains

Analyze Aurigene Oncology Limited engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aurigene.com00:00:12

See more with Sales Intelligence

Avg. pageviews on Aurigene Oncology Limited's top domains

See how Aurigene Oncology Limited keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aurigene.com1.32

See more with Sales Intelligence

Aurigene Oncology Limited top competitors by domain

Top similar sites in April 2026, ranked by their affinity

biocon.comCompany NameBioconEmployees> 10001HQIndia, BengaluruAnnual revenue$15M - $25MTotal visits81.2KHealth > Pharmacy

Top technologies used by Aurigene Oncology Limited

These are the website technologies, by industry, used by Aurigene Oncology Limited top domains

Payment & Currencies (11)

Cart Functionality

eCommerce (7)

Swap

Widget (5)

Twemoji

Advertising (4)

DoubleClick

More Technologies

7

See all

News & Signals from Aurigene Oncology Limited

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAurigene Oncology Limited launches proteolysis targeting chimera compounds comprising an E3 ubiquitin ligase CBL-B.Aurigene Oncology Ltd. and Olema Pharmaceuticals Inc. have disclosed new proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase CBL-B (CBLB)-binding moiety coupled to a histone acetyltransferase KAT6A (MOZ; MYST-3)-targeting moiety.

NewsAurigene Oncology Limited attends event AACR-NCI-EORTC International Conference 2025.Aurigene Oncology to showcase innovative A-PROX platform at the AACR-NCI-EORTC International Conference 2025.

NewsAurigene Oncology Limited is developing novel cell therapy medicines for difficult-to-treat solid tumors.Edity Therapeutics Limited and Aurigene Oncology Limited (AOL), a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited, a clinical-stage biotechnology company, announced a strategic collaboration to create novel cell therapy medicines for difficult-to-treat solid tumors.